Successful registrations in Argentina and the United Arab Emirates
Croma successfully registered the products Princess® Volume Lidocain and Princess® Filler Lidocain within nine months with the Argentinian ANMAT. The new distributor has already been able to acquire the necessary licenses for the import and distribution of Medical Devices Class IV, which means that there is nothing to prevent the launch and distribution in the Latin market.
Furthermore, those Princess® Injectables products without Lidocain have been successfully approved in the United Arab Emirates. Thus, CROMA's sales structure in the Arab region was strengthened by another country.
More products are on the verge of being approved in other countries.